Spiro Rombotis
2021
In 2021, Spiro Rombotis earned a total compensation of $1.3M as President and Chief Executive Officer at Cyclacel Pharmaceuticals, a 5% decrease compared to previous year.
Compensation breakdown
| Bonus | $265,277 |
|---|---|
| Option Awards | $499,700 |
| Salary | $530,553 |
| Other | $43,696 |
| Total | $1,339,226 |
Rombotis received $530.6K in salary, accounting for 40% of the total pay in 2021.
Rombotis also received $265.3K in bonus, $499.7K in option awards and $43.7K in other compensation.
Rankings
In 2021, Spiro Rombotis' compensation ranked 7,706th out of 12,415 executives tracked by ExecPay. In other words, Rombotis earned more than 37.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,706 out of 12,415 | 38th |
Division Manufacturing | 3,398 out of 5,505 | 38th |
Major group Chemicals And Allied Products | 1,506 out of 2,375 | 37th |
Industry group Drugs | 1,340 out of 2,096 | 36th |
Industry Pharmaceutical Preparations | 989 out of 1,546 | 36th |
Source: SEC filing on April 26, 2022.
Rombotis' colleagues
We found two more compensation records of executives who worked with Spiro Rombotis at Cyclacel Pharmaceuticals in 2021.
News
Cyclacel Pharmaceuticals CEO Spiro Rombotis' 2023 pay slips 13% to $661K
May 7, 2024
Cyclacel Pharmaceuticals CEO Spiro Rombotis' 2022 pay falls 43% to $764K
April 28, 2023
Cyclacel Pharmaceuticals CEO Spiro Rombotis' 2021 pay slips 5% to $1.3M
April 26, 2022
Cyclacel Pharmaceuticals CEO Spiro Rombotis' 2020 pay jumps 39% to $1.4M
April 29, 2021
Cyclacel Pharmaceuticals CEO Spiro Rombotis' 2019 pay jumps 35% to $1M
May 12, 2020